Nektar Therapeutics / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €102.46M +98.7% -€236.25M -18.8% -230.6% +3.3 pp N/A N/A
    (estimated) €51.56M +76.4% -€290.84M +30.5% -564.0% +2.0 pp N/A N/A
    (estimated) €29.22M -16.4% -€222.84M +24.6% -762.5% -2.5 pp €0.00 +NaN% 0.0% +0.0 pp
    (estimated) €34.94M -4.0% -€178.85M +12.0% -511.8% -0.73 pp €0.00 +NaN% 0.0% +0.0 pp
    (estimated) €36.38M -57.1% -€159.62M +55.7% -438.7% -3.2 pp €0.00 -100.0% 0.0% +1.8 pp
    €84.80M +9.2% -€102.49M -56.9% -120.9% +1.9 pp -€150.12M -9.1% -177.0% +0.36 pp
    €77.64M -2.1% -€237.84M -25.0% -306.3% +0.94 pp -€165.19M -35.7% -212.8% +1.1 pp
    €79.31M -9.7% -€317.22M -29.7% -400.0% +1.1 pp -€257.03M -25.0% -324.1% +0.66 pp
    €87.80M -33.4% -€451.31M +17.9% -514.0% -2.2 pp -€342.61M +29.9% -390.2% -1.9 pp
    €131.74M +33.4% -€382.91M +0.9% -290.6% +0.94 pp -€263.66M +1.2% -200.1% +0.64 pp
    €98.75M -90.4% -€379.66M -164.7% -384.5% -4.4 pp -€260.53M -141.3% -263.8% -3.3 pp
    €1.03B +287.8% €586.98M -804.6% 57.1% +0.89 pp €631.04M -1,135.4% 61.4% +0.84 pp
    €265.11M +86.0% -€83.30M -37.0% -31.4% +0.61 pp -€60.94M -36.1% -23.0% +0.44 pp
    €142.53M -28.3% -€132.27M +89.1% -92.8% -0.58 pp -€95.31M +78.8% -66.9% -0.40 pp
    €198.83M +15.0% -€69.94M +50.6% -35.2% -0.083 pp -€53.32M -53.1% -26.8% +0.39 pp
    €172.92M +34.8% -€46.45M -66.7% -26.9% +0.82 pp -€113.75M +283.4% -65.8% -0.43 pp
    €128.30M +83.4% -€139.58M -5.7% -108.8% +1.0 pp -€29.67M -71.1% -23.1% +1.2 pp
    €69.95M +13.6% -€148.06M +28.3% -211.7% -0.24 pp -€102.67M +14.6% -146.8% -0.013 pp
    €61.58M -55.1% -€115.43M +253.1% -187.4% -1.6 pp -€89.62M +326.1% -145.5% -1.3 pp
    €137.02M +121.1% -€32.69M -63.0% -23.9% +1.2 pp -€21.03M -140.4% -15.4% -0.99 pp
    €61.97M -20.2% -€88.33M +198.6% -142.5% -1.0 pp €52.07M -147.6% 84.0% +2.2 pp
    €77.70M -67.0% -€29.58M +4.8% -38.1% -0.26 pp -€109.35M -170.9% -140.7% -2.1 pp
    €235.23M +25.4% -€28.23M -78.8% -12.0% +0.59 pp €154.30M -355.2% 65.6% +0.98 pp
    €187.57M +72.4% -€133.33M -16.4% -71.1% +0.76 pp -€60.47M +16.9% -32.2% +0.15 pp
    €108.80M +10.5% -€159.48M +81.7% -146.6% -0.57 pp -€51.73M +17.9% -47.5% -0.030 pp
    €98.45M +7.5% -€87.78M +118.3% -89.2% -0.45 pp -€43.89M -11.3% -44.6% +0.095 pp
    €91.55M +12.0% -€40.22M -56.6% -43.9% +0.69 pp -€49.50M -2.0% -54.1% +0.078 pp
    €81.71M +22.4% -€92.59M -57.0% -113.3% +2.1 pp -€50.53M +256.5% -61.8% -0.41 pp
    €66.74M +50.0% -€215.39M +156.7% -322.7% -1.3 pp -€14.18M -190.9% -21.2% -0.56 pp
    €44.48M +24.8% -€83.92M +153.3% -188.7% -0.96 pp €15.60M +250.4% 35.1% +0.23 pp
    €35.63M +89.8% -€33.12M +109.5% -93.0% -0.087 pp €4.45M -66.4% 12.5% -0.58 pp
    €18.78M +34.1% -€15.81M +83.9% -84.2% -0.23 pp €13.23M -30.9% 70.5% -0.66 pp
    €14.00M +135.5% -€8.60M -0.2% -61.4% +0.83 pp €19.16M -717.8% 136.9% +1.9 pp
    €5.94M +102.9% -€8.62M +29.9% -144.9% +0.82 pp -€3.10M -10.0% -52.2% +0.65 pp
    €2.93M +100.0% -€6.63M +45.3% -226.5% +0.85 pp -€3.45M +53.8% -117.6% +0.35 pp
    €1.46M -€4.57M -311.8% -€2.24M -152.9%

    Notifications